Form 4: Disc Medicine Executive Acquires Shares and Stock Options

Pamela Stephenson, Chief Commercial Officer of Disc Medicine, Inc., reports acquisition of common stock and stock options.

Summary

• Pamela Stephenson, Chief Commercial Officer of Disc Medicine, Inc. (IRON), filed a Form 4 detailing changes in beneficial ownership.
• On February 26, 2024, Stephenson acquired 36,666 shares of common stock at $0.00.
• Stephenson also acquired stock options for 55,000 shares with an exercise price of $64.66, expiring on February 25, 2034.
• 25% of the options vest on February 26, 2025, with the remainder vesting in 36 equal monthly installments, contingent upon continued service.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of executive stock transactions. The vesting schedule suggests a positive outlook from the executive.

Positives

• The acquisition of shares and options by a key executive could be interpreted as a positive sign of confidence in the company's future prospects.

Future Outlook

The vesting schedule of the stock options indicates a long-term commitment from the executive.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions in publicly traded companies.

Stakeholder Impact

• Shareholders may view the executive's stock acquisition as a positive signal.

Key Dates